UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 344

Sortiert nach

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Alzheimer's & dementia : translational research & clinical interventions, 2019, Vol.5 (1), p.354-363

2019

Volltextzugriff (PDF)

The economic burden of schizophrenia in the United States in 2002

The journal of clinical psychiatry, 2005-09, Vol.66 (9), p.1122

2005

Volltextzugriff (PDF)

Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study

Clinical therapeutics, 2015-06, Vol.37 (6), p.1301-1316

2015

Volltextzugriff (PDF)

Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database

BMC geriatrics, 2018-10, Vol.18 (1), p.243-243, Article 243

2018

Volltextzugriff (PDF)

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

BMC psychiatry, 2010-01, Vol.10 (1), p.11-11, Article 11

2010

Volltextzugriff (PDF)

A framework for addressing Alzheimer's disease: Without a frame, the work has no aim

Alzheimer's & dementia, 2023-04, Vol.19 (4), p.1568-1578

2023

Volltextzugriff (PDF)

A Claims-Based Examination of Health Care Costs Among Spouses of Patients With Alzheimer's Disease

The journals of gerontology. Series A, Biological sciences and medical sciences, 2017-06, Vol.72 (6), p.811-817

2017

Volltextzugriff (PDF)

Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer's disease patients

BMC health services research, 2014-07, Vol.14 (1), p.291-291, Article 291

2014

Volltextzugriff (PDF)

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia

Patient preference and adherence, 2010-07, Vol.4 (default), p.263-271

2010

Volltextzugriff (PDF)

Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease

Journal of Alzheimer's disease, 2018-01, Vol.61 (1), p.295

2018

Volltextzugriff (PDF)

Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change

Health affairs (Millwood, Va.), 2008-05, Vol.27 (3), p.w185

2008

Volltextzugriff (PDF)

Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myeloma

Journal of medical economics, 2016-05, Vol.19 (5), p.477-486

2016

Volltextzugriff (PDF)

The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis

Critical care medicine, 2004-11, Vol.32 (11), p.2199-2206

2004

Volltextzugriff (PDF)

Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients

Journal of medical economics, 2017-02, Vol.20 (2), p.151-161

2017

Volltextzugriff (PDF)

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

Critical care medicine, 2003-01, Vol.31 (1), p.1-11

2003

Volltextzugriff (PDF)

Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial

Critical care medicine, 2004-11, Vol.32 (11), p.2207-2218

2004

Volltextzugriff (PDF)

Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies

Pharmacoepidemiology and drug safety, 2014-03, Vol.23 (3), p.268-277

2014

Volltextzugriff (PDF)

Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy change

The journal of clinical psychiatry, 2011-06, Vol.72 (6), p.787

2011

Volltextzugriff (PDF)

Persistence with biologic therapies in the Medicare coverage gap

The American journal of managed care, 2011-11, Vol.17 (11), p.753-759

2011

Volltextzugriff (PDF)

How Do US Health Care Payers React to and Use Pharmacoeconomic Information?

International journal of the economics of business, 2011-07, Vol.18 (2), p.317-330

2011

Volltextzugriff (PDF)

Costs associated with attempted suicide among individuals with bipolar disorder

The journal of mental health policy and economics, 2010-06, Vol.13 (2), p.87-92

2010

Volltextzugriff (PDF)

Framework for disclosing AD biomarker results following cognitive assessment within a pragmatic, multi‐country implementation evaluation

Alzheimer's & dementia, 2022-12, Vol.18 (S7), p.n/a

2022

Volltextzugriff (PDF)

Frequency, Health Care Resource Use (HCRU), and Costs Associated With Skeletal Related Events (SREs) In US Patients With Multiple Myeloma (MM)

Blood, 2013-11, Vol.122 (21), p.2968-2968

2013

Volltextzugriff (PDF)

Patient (Pt) and caregiver (Cg) perspectives in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.4-4

2012

Volltextzugriff (PDF)

Effect of Timing of Drotrecogin Alfa (Activated) Initiation and Other Predictors of Hospital Mortality, Length of Stay, and Costs in ICU Patients with Severe Sepsis

Chest, 2004-10, Vol.126 (4), p.722S-722S

2004

Volltextzugriff (PDF)

1 – 25 von 344

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(296)
Mit Volltextzugriff
(309)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

The economic burden of schizophrenia in the United States in 2002

Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study

Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

A framework for addressing Alzheimer's disease: Without a frame, the work has no aim

A Claims-Based Examination of Health Care Costs Among Spouses of Patients With Alzheimer's Disease

Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer's disease patients

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia

Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease

Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change

Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myeloma

The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis

Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial

Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies

Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy change

Persistence with biologic therapies in the Medicare coverage gap

How Do US Health Care Payers React to and Use Pharmacoeconomic Information?

Costs associated with attempted suicide among individuals with bipolar disorder

Framework for disclosing AD biomarker results following cognitive assessment within a pragmatic, multi‐country implementation evaluation

Frequency, Health Care Resource Use (HCRU), and Costs Associated With Skeletal Related Events (SREs) In US Patients With Multiple Myeloma (MM)

Patient (Pt) and caregiver (Cg) perspectives in non-small cell lung cancer (NSCLC)

Effect of Timing of Drotrecogin Alfa (Activated) Initiation and Other Predictors of Hospital Mortality, Length of Stay, and Costs in ICU Patients with Severe Sepsis

Suchergebnisse filtern